These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2530530

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J, Verbist L.
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [Abstract] [Full Text] [Related]

  • 3. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Cappelletty DM, Rybak MJ.
    Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
    [Abstract] [Full Text] [Related]

  • 4. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A, Jarlier V, Legrand P, Fournier G, Nicolas MH, Duval J.
    Presse Med; 1989 Oct 11; 18(32):1560-6. PubMed ID: 2530532
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Dec 11; 38(12):2902-4. PubMed ID: 7695280
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R, Navarro C, Egido P, Aspiroz C, Goñi P, Vergara Y, Garcia C, Duran E, Castillo J, Rubio MC.
    J Chemother; 2000 Feb 11; 12(1):17-21. PubMed ID: 10768511
    [Abstract] [Full Text] [Related]

  • 9. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H, Delmas C.
    Presse Med; 1989 Oct 11; 18(32):1551-2. PubMed ID: 2530529
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ.
    Diagn Microbiol Infect Dis; 2008 Oct 11; 62(2):210-5. PubMed ID: 18715733
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.
    Reinert RR, Lütticken R, Lemperle M, Bryskier A.
    J Antimicrob Chemother; 1999 Jun 11; 43 Suppl C():5-8. PubMed ID: 10404330
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H, Trupl J.
    Folia Microbiol (Praha); 1998 Jun 11; 43(1):68-70. PubMed ID: 9569631
    [Abstract] [Full Text] [Related]

  • 13. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.
    Negri MC, Morosini MI, Loza E, Baquero F.
    Antimicrob Agents Chemother; 1994 Jan 11; 38(1):122-5. PubMed ID: 8141563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
    Jones RN, Johnson DM.
    Diagn Microbiol Infect Dis; 1998 Jun 11; 31(2):373-6. PubMed ID: 9635912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
    Vanhoof R, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Nyssen HJ, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 Jun 11; 51(6):377-85. PubMed ID: 8997755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.